X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1329) 1329
humans (1319) 1319
rhabdomyosarcoma (856) 856
male (839) 839
female (759) 759
child (706) 706
child, preschool (576) 576
oncology (521) 521
adolescent (517) 517
infant (415) 415
pediatrics (395) 395
chemotherapy (390) 390
children (382) 382
rhabdomyosarcoma - pathology (368) 368
adult (347) 347
rhabdomyosarcoma - therapy (328) 328
surgery (327) 327
combined modality therapy (317) 317
cancer (314) 314
intergroup rhabdomyosarcoma (287) 287
radiotherapy (271) 271
tumors (267) 267
prognosis (255) 255
sarcoma (252) 252
antineoplastic combined chemotherapy protocols - therapeutic use (235) 235
rhabdomyosarcoma - surgery (235) 235
rhabdomyosarcoma - radiotherapy (209) 209
rhabdomyosarcoma - drug therapy (199) 199
treatment outcome (194) 194
abridged index medicus (191) 191
rhabdomyosarcoma - diagnosis (188) 188
care and treatment (174) 174
embryonal rhabdomyosarcoma (174) 174
diagnosis (170) 170
childhood (162) 162
retrospective studies (161) 161
rhabdomyosarcoma - mortality (159) 159
neoplasm staging (148) 148
pathology (143) 143
follow-up studies (135) 135
middle aged (131) 131
rhabdomyosarcoma, embryonal - pathology (128) 128
medicine & public health (126) 126
diagnosis, differential (121) 121
health aspects (120) 120
survival rate (120) 120
radiation therapy (119) 119
alveolar rhabdomyosarcoma (116) 116
metastasis (116) 116
hematology (107) 107
immunohistochemistry (107) 107
patients (104) 104
radiology, nuclear medicine & medical imaging (103) 103
tomography, x-ray computed (103) 103
aged (102) 102
soft-tissue sarcoma (102) 102
therapy (99) 99
analysis (98) 98
young adult (98) 98
head (92) 92
infant, newborn (92) 92
magnetic resonance imaging (92) 92
research (92) 92
biopsy (90) 90
disease-free survival (89) 89
rhabdomyosarcoma, embryonal - therapy (85) 85
radiotherapy dosage (84) 84
medical prognosis (81) 81
childhood rhabdomyosarcoma (79) 79
survival (79) 79
neck (78) 78
rhabdomyosarcoma, embryonal - drug therapy (77) 77
rhabdomyosarcoma, embryonal - surgery (75) 75
risk factors (75) 75
vincristine - administration & dosage (74) 74
rhabdomyosarcoma, embryonal - diagnosis (72) 72
case studies (70) 70
experience (70) 70
neoplasm recurrence, local (70) 70
urology & nephrology (70) 70
hematology, oncology and palliative medicine (69) 69
radiation (69) 69
rhabdomyosarcoma, embryonal - radiotherapy (69) 69
sarcoma - pathology (69) 69
otorhinolaryngology (68) 68
survival analysis (67) 67
adults (66) 66
case report (66) 66
soft tissue neoplasms - pathology (66) 66
fatal outcome (65) 65
antineoplastic agents - therapeutic use (64) 64
chemotherapy, adjuvant (64) 64
childrens oncology group (64) 64
dactinomycin - administration & dosage (64) 64
radiotherapy, adjuvant (64) 64
rhabdomyosarcoma, alveolar - pathology (62) 62
sarcoma - therapy (60) 60
medicine (59) 59
prognostic-factors (59) 59
soft tissue sarcoma (59) 59
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1616) 1616
French (21) 21
Spanish (18) 18
German (17) 17
Japanese (12) 12
Polish (6) 6
Chinese (4) 4
Italian (2) 2
Serbian (2) 2
Turkish (2) 2
Bulgarian (1) 1
Croatian (1) 1
Dutch (1) 1
Hungarian (1) 1
Korean (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
International Journal of Radiation Oncology Biology Physics, ISSN 0360-3016, 06/2012, Volume 83, Issue 2, pp. 720 - 726
Purpose: To analyze the effect of reduced-dose radiotherapy on local control in children with low-risk rhabdomyosarcoma (RMS) treated in the Children's... 
Radiotherapy | Local control | Low risk | Rhabdomyosarcoma | PARAMENINGEAL RHABDOMYOSARCOMA | INTERNATIONAL SOCIETY | INTERGROUP-RHABDOMYOSARCOMA | NONMETASTATIC RHABDOMYOSARCOMA | SURGICAL-MANAGEMENT | FAILURE | RADIATION-THERAPY | STUDY-IV | GROUP-III PATIENTS | ONCOLOGY | PATIENT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Lymph Node Excision | Prostatic Neoplasms - radiotherapy | Age Factors | Humans | Child, Preschool | Infant | Male | Rhabdomyosarcoma, Embryonal - surgery | Neoplasm, Residual | Young Adult | Rhabdomyosarcoma, Embryonal - secondary | Treatment Failure | Adult | Female | Urogenital Neoplasms - drug therapy | Orbital Neoplasms - surgery | Child | Infant, Newborn | Orbital Neoplasms - radiotherapy | Prostatic Neoplasms - drug therapy | Rhabdomyosarcoma, Embryonal - pathology | Quality Control | Prostatic Neoplasms - pathology | Drug Administration Schedule | Prostatic Neoplasms - surgery | Head and Neck Neoplasms - drug therapy | Orbital Neoplasms - pathology | Urogenital Neoplasms - pathology | Orbital Neoplasms - drug therapy | Lymphatic Metastasis | Rhabdomyosarcoma, Embryonal - drug therapy | Tumor Burden | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Radiotherapy Dosage - standards | Urogenital Neoplasms - radiotherapy | Adolescent | Combined Modality Therapy - methods | Urogenital Neoplasms - surgery | Rhabdomyosarcoma, Embryonal - radiotherapy | Second-Look Surgery | Head and Neck Neoplasms - surgery | Index Medicus | SURGERY | PATIENTS | NEOPLASMS | LYMPH NODES | FAILURES | RADIOLOGY AND NUCLEAR MEDICINE | ENDOXAN | RADIATION DOSES | RADIOTHERAPY | CHILDREN | CONTROL | HAZARDS
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 2, pp. 635 - 642
Purpose To report the clinical outcome and late side effect profile of proton radiotherapy in the treatment of children with parameningeal rhabdomyosarcoma... 
Radiology | Hematology, Oncology and Palliative Medicine | Conformal radiotherapy | Late effects | Proton radiotherapy | Parameningeal rhabdomyosarcoma | Pediatric | NECK RHABDOMYOSARCOMA | HEAD | INTERGROUP RHABDOMYOSARCOMA | INTERNATIONAL-SOCIETY | INTENSITY-MODULATED RADIOTHERAPY | NONMETASTATIC RHABDOMYOSARCOMA | SOFT-TISSUE | CHILDREN | CHILDHOOD-CANCER | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PEDIATRIC-ONCOLOGY | Follow-Up Studies | Protons - adverse effects | Humans | Child, Preschool | Protons - therapeutic use | Infant | Male | Radiotherapy - adverse effects | Organ Sparing Treatments - methods | Rhabdomyosarcoma - radiotherapy | Meningeal Neoplasms - drug therapy | Rhabdomyosarcoma, Alveolar - mortality | Massachusetts | Female | Rhabdomyosarcoma - drug therapy | Child | Rhabdomyosarcoma - mortality | Rhabdomyosarcoma, Alveolar - drug therapy | Rhabdomyosarcoma, Alveolar - radiotherapy | Treatment Outcome | Rhabdomyosarcoma, Embryonal - mortality | Rhabdomyosarcoma, Embryonal - drug therapy | Meningeal Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Meningeal Neoplasms - radiotherapy | Rhabdomyosarcoma, Embryonal - radiotherapy | Radiotherapy | Medical colleges | Nuclear radiation | Index Medicus | DIAGNOSIS | PATIENTS | NEOPLASMS | FAILURES | PHOTONS | TEETH | RADIATION DOSES | CARIES | HISTOLOGY | PROTONS | SINUSES | MEDICAL RECORDS | NOSE | RADIATION DOSE UNITS | RADIOLOGY AND NUCLEAR MEDICINE | PEDIATRICS | RADIOTHERAPY | SIDE EFFECTS | COBALT | CONTROL
Journal Article
Journal Article
International Journal of Radiation Oncology Biology Physics, ISSN 0360-3016, 04/2012, Volume 82, Issue 5, pp. 1764 - 1770
Purpose: To compare the dosimetric parameters of intensity-modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3D-CRT) in patients with... 
Intensity-modulated radiotherapy | 3D-CRT | IMRT | Three-dimensional conformal radiotherapy | Rhabdomyosarcoma | Intermediate risk | TISSUE | CANCER | RADIATION-THERAPY | TRIAL | ONCOLOGY | NECK-RHABDOMYOSARCOMA | CARCINOMA | SURVIVORS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Organs at Risk - radiation effects | Humans | Rhabdomyosarcoma - pathology | Male | Radiotherapy, Intensity-Modulated - adverse effects | Rhabdomyosarcoma - radiotherapy | Rhabdomyosarcoma, Alveolar - mortality | Treatment Failure | Sarcoma - mortality | Female | Rhabdomyosarcoma - drug therapy | Rhabdomyosarcoma, Alveolar - pathology | Child | Rhabdomyosarcoma - mortality | Sarcoma - radiotherapy | Rhabdomyosarcoma, Embryonal - pathology | Radiotherapy, Intensity-Modulated - mortality | Rhabdomyosarcoma, Alveolar - drug therapy | Radiotherapy, Intensity-Modulated - methods | Rhabdomyosarcoma, Alveolar - radiotherapy | Rhabdomyosarcoma, Embryonal - mortality | Rhabdomyosarcoma, Embryonal - drug therapy | Sarcoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Epidemiologic Methods | Radiotherapy, Conformal - mortality | Radiotherapy, Conformal - adverse effects | Rhabdomyosarcoma, Embryonal - radiotherapy | Radiotherapy, Conformal - methods | Nuclear radiation | Analysis | Radiation | Medical care | Universities and colleges | Radiotherapy | Methods | Quality management | Index Medicus | PATIENTS | NEOPLASMS | INTEGRAL DOSES | FAILURES | TOXICITY | COMPARATIVE EVALUATIONS | CHILDREN | PLANNING | MULTIVARIATE ANALYSIS | RADIOLOGY AND NUCLEAR MEDICINE | REGRESSION ANALYSIS | RADIOTHERAPY | CONTROL | HAZARDS
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 5, pp. 1070 - 1077
Journal Article
Journal of Hematology and Oncology, ISSN 1756-8722, 10/2017, Volume 10, Issue 1, pp. 161 - 161
Background: EPH (erythropoietin-producing hepatocellular) receptors are clinically relevant targets in several malignancies. This report describes the effects... 
Cancer stem cell | GLPG1790 | Ephrin | Radiation therapy | Rhabdomyosarcoma | Tumour xenografts | PATHWAYS | CYCLIN D1 | PHOSPHORYLATION | FAMILY-MEMBERS | TUMOR | TYROSINE KINASES | CANCER | ONCOLOGY | GROWTH | MEK/ERK | HEMATOLOGY | EXPRESSION | Rhabdomyosarcoma, Embryonal - enzymology | Signal Transduction | Humans | Child, Preschool | Infant | Male | Rhabdomyosarcoma, Embryonal - drug therapy | Radiation Tolerance - drug effects | Xenograft Model Antitumor Assays | Animals | Receptors, Eph Family - antagonists & inhibitors | Transfection | Cell Differentiation - drug effects | Mice, Nude | Adolescent | Cell Line, Tumor | Female | Mice | Receptors, Eph Family - metabolism | Child | Rhabdomyosarcoma, Embryonal - radiotherapy | Infant, Newborn | Rhabdomyosarcoma, Embryonal - pathology | Antimitotic agents | Complications and side effects | Erythropoietin | Physiological aspects | Genetic aspects | Dosage and administration | Research | Drug therapy | Antineoplastic agents | Flow cytometry | Animal models | DNA damage | Bladder | Families & family life | Kinases | Cancer therapies | DNA repair | Cyclin B1 | Western blotting | Signal transduction | Cell growth | Cyclin A | Xenografts | Deoxyribonucleic acid--DNA | Phenotypes | Myogenin | Gene expression | Double-strand break repair | Patients | Eph protein | Myogenesis | CXCR4 protein | Skeletal muscle | Musculoskeletal system | Medical prognosis | Cell lines | Stem cells | Ligands | Immunofluorescence | Tumors | Index Medicus
Journal Article
Pediatric Blood and Cancer, ISSN 1545-5009, 05/2011, Volume 56, Issue 5, pp. 718 - 724
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 92, Issue 2, pp. 358 - 367
Journal Article
Journal of Pediatric Surgery, ISSN 0022-3468, 2011, Volume 46, Issue 11, pp. 2071 - 2075
Abstract Background/Purpose The aim of this study was to retrospectively analyze the clinical presentation, histology, treatment, and outcomes of children with... 
Pediatrics | Surgery | Germ cell tumor | Adenocarcinoma | Rhabdomyosarcoma | Vaginal tumors | SURGERY | INTERGROUP RHABDOMYOSARCOMA | PELVIC RHABDOMYOSARCOMA | GERM-CELL TUMORS | CONSERVATIVE SURGERY | CHEMOTHERAPY | GENITAL-TRACT | THERAPY | ADVANCED CERVICAL-CANCER | PEDIATRICS | ENDODERMAL SINUS TUMOR | Neoplasms, Germ Cell and Embryonal - radiotherapy | Prognosis | Hospitals, Pediatric - statistics & numerical data | Humans | Child, Preschool | Organ Sparing Treatments | Rhabdomyosarcoma - pathology | Adenocarcinoma, Clear Cell - radiotherapy | Infant | Vaginal Neoplasms - surgery | Vaginal Neoplasms - drug therapy | Neoplasms, Germ Cell and Embryonal - diagnosis | Rhabdomyosarcoma - radiotherapy | Hemorrhage - etiology | Female | Neoplasms, Germ Cell and Embryonal - drug therapy | Rhabdomyosarcoma - drug therapy | Brachytherapy | Retrospective Studies | Child | Vaginal Neoplasms - radiotherapy | Adenocarcinoma, Clear Cell - epidemiology | Adenocarcinoma, Clear Cell - surgery | Rhabdomyosarcoma - diagnosis | Neoplasms, Germ Cell and Embryonal - epidemiology | Colonic Neoplasms - epidemiology | Vaginal Neoplasms - pathology | Treatment Outcome | Combined Modality Therapy | Postoperative Complications - epidemiology | Adenocarcinoma, Clear Cell - diagnosis | Hysterectomy | Tennessee - epidemiology | Neoplasms, Second Primary - epidemiology | Disease-Free Survival | Vaginal Neoplasms - epidemiology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Rhabdomyosarcoma - epidemiology | Adenocarcinoma, Clear Cell - pathology | Neoplasms, Germ Cell and Embryonal - surgery | Rhabdomyosarcoma - surgery | Early Diagnosis | Neoplasms, Germ Cell and Embryonal - pathology | Vaginal Neoplasms - diagnosis | Adenocarcinoma, Clear Cell - drug therapy | Children's hospitals | Analysis | Tumors | Index Medicus
Journal Article
Journal Article
Zhonghua zhong liu za zhi [Chinese journal of oncology], ISSN 0253-3766, 12/2012, Volume 34, Issue 12, p. 910
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 87, Issue 3, pp. 512 - 516
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 1, pp. e61 - e66
Journal Article
American Journal of Otolaryngology--Head and Neck Medicine and Surgery, ISSN 0196-0709, 2014, Volume 35, Issue 6, pp. 814 - 815
Journal Article